2025 · 3rd Quarter (July 1 - Sep 30)
Filed by MEHLMAN CONSULTING, INC..
Open official filingSource-reported fields
Literal source text
Prescription drug pricing issues. S. 229 Drug-price Transparency for Consumers (DTC) Act. H.R. 3789 - The Drug-price Transparency for Consumers (DTC) Act. H.R. 1/PL 119-21 - One Big Beautiful Bill Act.
Literal federal measure citations: S. 229, H.R. 3789, H.R. 1
Prescription drug pricing issues. H.R. 1843/S. 1032 - Increasing Transparency in Generic Drug Applications Act. S. 1954 - Biosimilar Red Tape Elimination Act; S. 1095 - Stop Stalling Act S. 1067 - Ensuring Timely Access to Generics Act; S. 2630 - REMEDY Act
Literal federal measure citations: H.R. 1843, S. 1032, S. 1954, S. 1095, S. 1067, S. 2630
Patent abuse issues. S.1040 - Drug Competition Enhancement Act. S.1041 - Affordable Prescriptions for Patients Act. S.1096 - Preserve Access to Affordable Generics and Biosimilars Act. S.1095 - Stop STALLING Act. S. 1097 - Interagency Patent Coordination and Improvement Act of 2025. S. 43 - Skinny Labels, Big Savings Act. H.R. 3269/S. 2276 - ETHIC Act. S. 2658 - Medication Affordability and Patent Integrity Act. H.R. 3160/s. 1533 - the Prevail Act. H.R. 3152/S. 1546 - Patient Eligibility Restoration Act. H.R. 3010/S. 1785 - the No Handouts for Drug Advertisement Act.
Literal federal measure citations: S.1040, S.1041, S.1096, S.1095, S. 1097, S. 43, H.R. 3269, S. 2276, S. 2658, H.R. 3160, s. 1533, H.R. 3152, S. 1546, H.R. 3010, S. 1785
Bill links use only the filing year’s mathematically derived Congress plus the literal measure type and number in the issue description. Unmatched citations remain plain text. Politically.com does not join on names, infer advocacy positions, combine amendments, or calculate totals across filings.
